ArchivesMagazine - 15 Nov 2018Time to load up on AstraZeneca for capital gains and dividends The FTSE 100 pharma giant is now looking more attractive after a long period in the doldrums 15 November 2018|Great Ideas Issue: 15 Nov 2018 - Page 10 < Supermarket sales slow after summer surprise Why we think National Grid is a firm buy for the future > Issue: 15 Nov 2018 - Page 10 | Contents Next: Why we think National Grid is a firm buy for the future Previous: Supermarket sales slow after summer surprise Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Daniel Coatsworth Issue Contents Aequitas Why Warren Buffett seems to be running scared of bonds Ask Tom 'How does pension tax relief work?' Big News Dividend relief lifts Vodafone Supermarket sales slow after summer surprise Are investors overreacting to talk of a possible US ban on menthol cigarettes? UK economic outlook flags risks for banks and consumer-facing businesses Tracsis rules out cash return as acquisition pipeline bulges Editor's View Are we entering a bear market and does it matter? Feature Which small cap pharma firms make a profit? Funds Blue Whale goes straight to the top end of the fund chart Find out how ETFs are getting active Great Ideas Why we think National Grid is a firm buy for the future Time to load up on AstraZeneca for capital gains and dividends Great Ideas Update Experian continues to tick the right boxes On The Beach hit by sector woes Investment Trusts Do capital preservation funds perform as planned? Can retail investors bag a unicorn? Main Feature Turn patience into profit Money Matters How to save money when you’re investing Talking Point Could logistics firms benefit from stockpiling ahead of Brexit?